Gaurav A Upadhyay to Treatment Outcome
This is a "connection" page, showing publications Gaurav A Upadhyay has written about Treatment Outcome.
Connection Strength
1.471
-
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients with mid-range ejection fraction. J Interv Card Electrophysiol. 2025 Jan; 68(1):111-116.
Score: 0.095
-
Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring. J Am Coll Cardiol. 2023 03 14; 81(10):949-961.
Score: 0.086
-
Physiologic Pacing Targeting the His Bundle and Left Bundle Branch: a Review of the Literature. Curr Cardiol Rep. 2022 08; 24(8):959-978.
Score: 0.082
-
Population-Level Impact of the Guidelines Update on Patient Selection and Outcomes After Cardiac Resynchronization Therapy. JACC Clin Electrophysiol. 2022 05; 8(5):651-661.
Score: 0.081
-
Bradyarrhythmias and Physiologic Pacing in the ICU. J Intensive Care Med. 2022 May; 37(5):595-610.
Score: 0.076
-
Keeping pace with the competition: His bundle versus biventricular pacing in heart failure. Curr Opin Cardiol. 2020 05; 35(3):295-307.
Score: 0.071
-
Catheter Ablation for Atrial Fibrillation in 2019. JAMA. 2019 08 20; 322(7):686-687.
Score: 0.068
-
On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial. Heart Rhythm. 2019 12; 16(12):1797-1807.
Score: 0.066
-
Pushing and recognizing the limits of nonresponse to cardiac resynchronization therapy: A valuable "negative" trial. Heart Rhythm. 2018 06; 15(6):877-878.
Score: 0.061
-
Does Cardiac Resynchronization Therapy Benefit Patients with Non-Left Bundle Branch Block Prolonged QRS Patterns? Curr Cardiol Rep. 2017 10 24; 19(12):125.
Score: 0.060
-
Selective versus non-selective his bundle pacing for cardiac resynchronization therapy. J Electrocardiol. 2017 Mar - Apr; 50(2):191-194.
Score: 0.055
-
Cause of death and CRT device selection: striving for certitude? Eur Heart J. 2015 Nov 01; 36(41):2777-9.
Score: 0.051
-
Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm. 2015 Jun; 12(6):1201-8.
Score: 0.049
-
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial. Circ Arrhythm Electrophysiol. 2024 Dec; 17(12):e012836.
Score: 0.024
-
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial. Circ Cardiovasc Qual Outcomes. 2024 11; 17(11):e010822.
Score: 0.024
-
Multicenter Hemodynamic Assessment of the LOT-CRT Strategy: When Does Combining Left Bundle Branch Pacing and Coronary Venous Pacing Enhance Resynchronization?: Primary Results of the CSPOT Study. Circ Arrhythm Electrophysiol. 2024 Nov; 17(11):e013059.
Score: 0.024
-
Association between COVID-19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices. J Cardiovasc Electrophysiol. 2024 Sep; 35(9):1828-1836.
Score: 0.024
-
Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry. J Am Heart Assoc. 2024 Aug 06; 13(15):e034500.
Score: 0.024
-
Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registry. Europace. 2024 Jul 02; 26(7).
Score: 0.024
-
Septal venous channel perforation during left bundle branch area pacing: a prospective study. Europace. 2024 Jun 03; 26(6).
Score: 0.024
-
Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease. J Surg Res. 2004 Mar; 117(1):71-8.
Score: 0.023
-
Left Bundle Branch Block: Characterization, Definitions, and Recent Insights into Conduction System Physiology. Cardiol Clin. 2023 Aug; 41(3):379-391.
Score: 0.022
-
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System. J Am Coll Cardiol. 2023 08 01; 82(5):383-397.
Score: 0.022
-
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm. 2023 09; 20(9):e17-e91.
Score: 0.022
-
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial. Eur Heart J. 2022 12 14; 43(47):4872-4883.
Score: 0.021
-
Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group. Heart Rhythm. 2022 08; 19(8):1272-1280.
Score: 0.020
-
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial. Circulation. 2022 02; 145(5):321-329.
Score: 0.020
-
Left ventricle and mitral valve reverse remodeling in response to cardiac resynchronization therapy in nonischemic cardiomyopathy. Echocardiography. 2020 10; 37(10):1557-1565.
Score: 0.018
-
Characterization of Lead Adherence Using Intravascular Ultrasound to Assess Difficulty of Transvenous Lead Extraction. Circ Arrhythm Electrophysiol. 2020 08; 13(8):e007726.
Score: 0.018
-
The effects of cardiac resynchronization therapy on left ventricular and mitral valve geometry and secondary mitral regurgitation in patients with left bundle branch block. Echocardiography. 2019 08; 36(8):1450-1458.
Score: 0.017
-
Effects of cardiac resynchronization therapy after inferior myocardial infarction on secondary mitral regurgitation and mitral valve geometry. Pacing Clin Electrophysiol. 2018 02; 41(2):114-121.
Score: 0.015
-
Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation. Echocardiography. 2017 Nov; 34(11):1561-1567.
Score: 0.015
-
Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol. 2017 12 11; 3(12):1412-1424.
Score: 0.015
-
Permanent His-bundle pacing for cardiac resynchronization therapy: Initial feasibility study in lieu of left ventricular lead. Heart Rhythm. 2017 09; 14(9):1353-1361.
Score: 0.014
-
Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2015 Oct; 38(10):1192-200.
Score: 0.013
-
Does prior valve surgery change outcome in patients treated with cardiac resynchronization therapy? J Cardiovasc Electrophysiol. 2014 Nov; 25(11):1206-13.
Score: 0.012
-
Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy. JACC Heart Fail. 2014 Jun; 2(3):230-7.
Score: 0.012
-
Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure. Am J Cardiol. 2014 May 01; 113(9):1523-8.
Score: 0.012
-
Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014 May; 25(5):507-513.
Score: 0.011
-
QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. Eur Heart J. 2013 Aug; 34(29):2252-62.
Score: 0.011
-
The anatomic and electrical location of the left ventricular lead predicts ventricular arrhythmia in cardiac resynchronization therapy. Heart Rhythm. 2013 May; 10(5):668-75.
Score: 0.011
-
Right ventricular lead adjustment in cardiac resynchronization therapy and acute hemodynamic response: a pilot study. J Interv Card Electrophysiol. 2013 Apr; 36(3):223-31.
Score: 0.011
-
Electrical delay in apically positioned left ventricular leads and clinical outcome after cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2013 Feb; 24(2):182-7.
Score: 0.010
-
Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure. Am J Cardiol. 2012 Sep 01; 110(5):683-8.
Score: 0.010
-
Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J. 2012 Sep; 33(17):2181-8.
Score: 0.010
-
Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis. Heart Rhythm. 2011 Jul; 8(7):994-1000.
Score: 0.009
-
An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn's disease. Dis Colon Rectum. 2007 Mar; 50(3):277-84.
Score: 0.007